Kirk Randal J's Form 4 filing
Precigen, Inc. (PGEN) · filed Dec 29, 2023
- Accession no.
- 0001213900-23-100214
- Filed
- Dec 29, 2023
- Trade date
- Dec 28, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $136.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kirk Randal JCIK 0001091823 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 28, 2023 | Common Stock | PPurchaseAcquired | +96,686 | $1.41F1 | +$136,327.26 | 1,096,686 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On December 28, 2023, Parkview 2020 Limited Partnership ("Parkview 2020"), entered into a Stock Purchase Agreement with Jeffrey Kindler, a Director of the issuer, pursuant to which Parkview 2020 purchased from Mr. Kindler 96,686 shares of common stock of the issuer for an aggregate purchase price of $1.41, which purchase price was calculated based upon the closing price of the issuer's common stock on December 28, 2023.
Referenced by the price of 1 transaction in Table I.